ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure

ClinicalTrials.gov ID: NCT01731002

Public ClinicalTrials.gov record NCT01731002. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 21, 2026, 1:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-masked, Randomized, Multi-center, Active-controlled, Dose-response Parallel-group Study Comparing the Safety and Ocular Hypotensive Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure

Study identification

NCT ID
NCT01731002
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Aerie Pharmaceuticals
Industry
Enrollment
224 participants

Conditions and interventions

Interventions

  • AR-13324 Ophthalmic Solution 0.01% Drug
  • AR-13324 Ophthalmic Solution 0.02% Drug
  • Latanoprost ophthalmic solution 0.005% Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2012
Primary completion
Apr 30, 2013
Completion
Apr 30, 2013
Last update posted
Apr 16, 2018

2012 – 2013

United States locations

U.S. sites
22
U.S. states
12
U.S. cities
22
Facility City State ZIP Site status
Kenneth Sall, M.D. Artesia California 90701
United Medical Research Institute Inglewood California 90301
Aesthetic Eye Care Institute Newport Beach California 92657
North Bay Eye Associates Petaluma California 94954
Centre For Health Care Poway California 92064
Clayton Eye Center Morrow Georgia 30260
Coastal Research Associates, LLC Roswell Georgia 30076
Bradley Kwapiszeski, MD Shawnee Mission Kansas 66204
Taustine Eye Center Louisville Kentucky 40217
Alan L Robin, M.D. Baltimore Maryland 21209
Seidenberg Protzko Eye Associates Havre de Grace Maryland 21078
Great Lakes Eye Care Saint Joseph Michigan 49085
Ophthalmic Consultants of Long Island Lynbrook New York 11563
Rochester Ophthalmological Group Rochester New York 14618
Charlotte Eye Ear Nose and Throat Charlotte North Carolina 28210
Michael E. Tepedino, M.D. High Point North Carolina 27262
The Eye Institute Tulsa Oklahoma 74104
Wills Eye Hospital Philadelphia Pennsylvania 19107
Texan Eye Austin Texas 78731
Cataract & Glaucoma Center El Paso Texas 79902
Medical Center Ophth. Associates San Antonio Texas 78731
Virginia Eye Consultants Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01731002, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2018 · Synced May 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01731002 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →